GeneNews to Begin Trading on TSX on October 26, 2006
Former ChondroGene Graduates with New Symbol: GEN
TORONTO, CANADA (October 25, 2006): GeneNews Limited (TSX Venture: CDG) is pleased to report that its common shares will commence trading on the Toronto Stock Exchange ('TSX') at the open of trading on October 26, 2006 under the symbol 'GEN'.
The common shares of GeneNews Limited™ (formerly ChondroGene Limited™) which are currently listed and trading on the Toronto Venture Exchange ('TSX-V') under the symbol 'CDG' will be de-listed and cease trading on the TSX-V after October 25, 2006, as a result of the Company's graduation to the TSX. The Company’s common shares will thereafter be listed and tradable on the TSX under the symbol 'GEN'.
"Our graduation to the TSX is an important milestone for us as we continue with the development and commercialization of our first product, ColonSentry™", stated K. Wayne Marshall, President and CEO of GeneNews. "The listing of our shares on the TSX will enhance our visibility in the public markets and make our Company shares accessible to a new group of retail and institutional investors."
The Company received conditional approval to list its common shares on the TSX on September 20, 2006, and received shareholder approval to change its name to GeneNews Limited at its last Annual Meeting held on June 12, 2006.
Forward-Looking Statements
This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.
